| scholarly article | Q13442814 |
| P50 | author | Sergi Ferré | Q39025293 |
| Diego Dal Ben | Q43259191 | ||
| Gianfabio Giorgioni | Q57539490 | ||
| Ajiroghene Thomas | Q58905302 | ||
| Alessandro Bonifazi | Q58915030 | ||
| Thomas M Keck | Q63622143 | ||
| Fabio Del Bello | Q91825413 | ||
| P2093 | author name string | Amy H Newman | |
| Alessandro Piergentili | |||
| Maria Pigini | |||
| Mario Giannella | |||
| Wilma Quaglia | |||
| Valerio Mammoli | |||
| Marta Sanchez-Soto | |||
| P2860 | cites work | Dopamine receptors: from structure to function | Q24336139 |
| Multiple dopamine D4 receptor variants in the human population | Q24336675 | ||
| Structure of the Human Dopamine D3 Receptor in Complex with a D2/D3 Selective Antagonist | Q27666030 | ||
| Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction | Q27860958 | ||
| Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics | Q28258681 | ||
| AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility | Q29547658 | ||
| A semiempirical free energy force field with charge-based desolvation | Q29614316 | ||
| Evidence of positive selection acting at the human dopamine receptor D4 gene locus | Q33897512 | ||
| RO-10-5824 is a selective dopamine D4 receptor agonist that increases novel object exploration in C57 mice | Q34184781 | ||
| A-412997 is a selective dopamine D4 receptor agonist in rats | Q34449795 | ||
| 1-aryl-3-(4-pyridine-2-ylpiperazin-1-yl)propan-1-one oximes as potent dopamine D4 receptor agonists for the treatment of erectile dysfunction | Q34557924 | ||
| Discovery of 3-methyl-N-(1-oxy-3',4',5',6'-tetrahydro-2'H-[2,4'-bipyridine]-1'-ylmethyl)benzamide (ABT-670), an orally bioavailable dopamine D4 agonist for the treatment of erectile dysfunction | Q34588139 | ||
| The combinatorial synthesis of bicyclic privileged structures or privileged substructures. | Q35083549 | ||
| Current perspectives on selective dopamine D(3) receptor antagonists as pharmacotherapeutics for addictions and related disorders | Q35143623 | ||
| Small-molecule library screening by docking with PyRx | Q35548740 | ||
| Blockade of dopamine d4 receptors attenuates reinstatement of extinguished nicotine-seeking behavior in rats | Q35679955 | ||
| Identifying Medication Targets for Psychostimulant Addiction: Unraveling the Dopamine D3 Receptor Hypothesis | Q35892818 | ||
| Ring substituents on substituted benzamide ligands indirectly mediate interactions with position 7.39 of transmembrane helix 7 of the D4 dopamine receptor | Q36105365 | ||
| Privileged structures as leads in medicinal chemistry. | Q36386430 | ||
| Sol-gel chemistry in medicinal science. | Q36386439 | ||
| The dopamine D3 receptor: a therapeutic target for the treatment of neuropsychiatric disorders | Q36448714 | ||
| Recent progress in development of dopamine receptor subtype-selective agents: potential therapeutics for neurological and psychiatric disorders | Q36702967 | ||
| Novel insights in dopamine receptor physiology | Q36782648 | ||
| MOPAC: a semiempirical molecular orbital program | Q37328051 | ||
| Current perspectives on the selective regulation of dopamine D₂ and D₃ receptors | Q37807297 | ||
| Recent advances in the search for D3- and D4-selective drugs: probes, models and candidates | Q37828272 | ||
| Dopamine D3 receptor antagonists: a patent review (2007 - 2012). | Q38071135 | ||
| Biologically active compounds based on the privileged 2-imidazoline scaffold: The world beyond adrenergic/imidazoline receptor modulators. | Q38281634 | ||
| Low Doses of Allyphenyline and Cyclomethyline, Effective against Morphine Dependence, Elicit an Antidepressant-like Effect. | Q39734497 | ||
| Exploring multitarget interactions to reduce opiate withdrawal syndrome and psychiatric comorbidity | Q39778292 | ||
| Dopamine D4 ligands and models of receptor activation: 2-(4-pyridin-2-ylpiperazin-1-ylmethyl)-1H-benzimidazole and related heteroarylmethylarylpiperazines exhibit a substituent effect responsible for additional efficacy tuning | Q40567031 | ||
| Antagonism/Agonism modulation to build novel antihypertensives selectively triggering i1-imidazoline receptor activation | Q40753365 | ||
| Alpha2-adrenoreceptors profile modulation and high antinociceptive activity of (S)-(-)-2-[1-(biphenyl-2-yloxy)ethyl]-4,5-dihydro-1H-imidazole. | Q40761171 | ||
| Distribution of dopamine D3 receptor expressing neurons in the human forebrain: comparison with D2 receptor expressing neurons | Q42466412 | ||
| Fruitful adrenergic α(2C)-agonism/α(2A)-antagonism combination to prevent and contrast morphine tolerance and dependence | Q42868591 | ||
| Novel imidazoline compounds as partial or full agonists of D2-like dopamine receptors inspired by I2-imidazoline binding sites ligand 2-BFI. | Q42923558 | ||
| Imaging dopamine D3 receptors in the human brain with positron emission tomography, [11C]PHNO, and a selective D3 receptor antagonist. | Q42990725 | ||
| Might adrenergic alpha2C-agonists/alpha2A-antagonists become novel therapeutic tools for pain treatment with morphine? | Q43249450 | ||
| Nefiracetam attenuates methamphetamine-induced discriminative stimulus effects in rats | Q45149998 | ||
| Effects of L-745,870, a dopamine D4 receptor antagonist, on naloxone-induced morphine dependence in mice | Q45150035 | ||
| Modeling the similarity and divergence of dopamine D2-like receptors and identification of validated ligand-receptor complexes | Q45249701 | ||
| Dopamine agonist-induced penile erection and yawning: a comparative study in outbred Roman high- and low-avoidance rats | Q45851507 | ||
| Novel ligands rationally designed for characterizing I2-imidazoline binding sites nature and functions | Q46459250 | ||
| Involvement of dopamine D3 and D4 receptors in the discriminative stimulus properties of cocaine in the rat. | Q46853733 | ||
| Investigation of allyphenyline efficacy in the treatment of alcohol withdrawal symptoms. | Q47712456 | ||
| Discriminative-stimulus effects of methamphetamine and morphine in rats are attenuated by cAMP-related compounds. | Q48466809 | ||
| Labelling of I2B-imidazoline receptors by [3H]2-(2-benzofuranyl)-2-imidazoline (2-BFI) in rat brain and liver: characterization, regulation and relation to monoamine oxidase enzymes. | Q48670124 | ||
| Highly regioselective anti-markovnikov palladium-borate-catalyzed methoxycarbonylation reactions: unprecedented results for aryl olefins. | Q50704903 | ||
| PD168077, a D(4) receptor agonist, reverses object recognition deficits in rats: potential role for D(4) receptor mechanisms in improving cognitive dysfunction in schizophrenia. | Q51030175 | ||
| A Second Generation Force Field for the Simulation of Proteins, Nucleic Acids, and Organic Molecules | Q55918670 | ||
| Substituted [(4-phenylpiperazinyl)-methyl]benzamides: selective dopamine D4 agonists | Q73435279 | ||
| A C-glucosylflavone from leaves of Piper lhotzkyanum | Q73468165 | ||
| Favourable involvement of α2A-adrenoreceptor antagonism in the I₂-imidazoline binding sites-mediated morphine analgesia enhancement | Q83523463 | ||
| P433 | issue | 16 | |
| P921 | main subject | 2-imidazoline | Q419555 |
| P304 | page(s) | 1819-1828 | |
| P577 | publication date | 2016-03-15 | |
| P1433 | published in | ChemMedChem | Q2962252 |
| P1476 | title | A Novel Class of Dopamine D4 Receptor Ligands Bearing an Imidazoline Nucleus | |
| P478 | volume | 11 |
Search more.